Stem cells and neurodegenerative diseases

Science in China, Series C: Life Sciences

Volumn 51, Issue 4, 2008, Pages 287-294

  Hou, LingLing ^a   Hong, Tao ^a  

^a BEIJING JIAOTONG UNIVERSITY   (China)

Author keywords

Neurodegenerative diseases; Stem cells; Therapy

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; DEGENERATIVE DISEASE; HUMAN; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 43349097143     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-008-0049-1     Document Type: Review

References (54)

1. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-How to make it work. Nat Med, 2004, 10: S42-S50
2. Piccini P, Brooks D J, Bjorklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci, 1999, 2(12): 1137-1140
3. Piccini P, Lindvall O, Bjorklund A, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol, 2000, 48(5): 689-695
4. Studer L, Tabar V, McKay R D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci, 1998, 1(4): 290-295
5. Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res, 2000, 127: 299-320
6. Sanchez-Pernaute R, Studer L, Bankiewicz K S, et al. In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res, 2001, 65: 284-288
7. Polgar S, Morris M E, Reilly S, et al. Reconstructive neurosurgery for Parkinson's disease: A systematic review and preliminary meta-analysis. Brain Res Bull, 2003, 60(1-2): 1-24
8. Freed C R, Greene P E, Breeze R E, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med, 2001, 344(10): 710-719
9. Olanow C W, Goetz C G, Kordower J H, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol, 2003, 54(3): 403-414
10. Bjorklund L M, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA, 2002, 99(4): 2344-2349
11. Kim J H, Auerbach J M, Rodriguez-Gomez J A, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 2002, 418(6893): 50-56
12. Nishimura F, Yoshikawa M, Kanda S, et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells, 2003, 21(2): 171-180
13. Takagi Y, Takahashi J, Saiki H, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest, 2005, 115(1): 102-109
14. Hellmann M A, Panet H, Barhum Y, et al. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett, 2006, 395(2): 124-128
15. Weiss M L, Medicetty S, Bledsoe A R, et al. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 2006, 24(3): 781-792
16. Fu Y S, Cheng Y C, Lin M Y, et al. Conversion of human umbilical cord mesenchymal stem cells in wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. Stem Cells, 2006, 24(1): 115-124
17. Crigler L, Robey R C, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol, 2006, 198: 54-64
18. Munoz J R, Stoutenger B R, Robinson A P, et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA, 2005, 102(50): 18171-18176
19. Harrower T P, Tyers P, Hooks Y, et al. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. Exp Neurol, 2006, 197(1): 56-69
20. Bjugstad K B, Redmond D E, Teng Y D, et al. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transplant, 2005, 14(4): 183-192
21. Redmond D E, Bjugstad K B, Teng Y D, et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA, 2007, 104(29): 12175-12180
22. Auld D S, Kornecook T J, Bastianetto S, et al. Alzheimer's disease and the basal forebrain cholinergic system: Relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol, 2002, 68: 209-245
23. German D C, Yazdani U, Speciale S G, et al. Cholinergic neuropathology in a mouse model of Alzheimer's disease. J Comp Neurol, 2003, 462: 371-373
24. Martinez-Serrano A, Hantzopoulos P A, Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: Neurotrophic effects on cholinergic neurons. Eur J Neurosci, 1996, 8: 727-735
25. Sinden J D, Stroemer P, Grigoryan G, et al. Functional repair with neural stem cells. Novartis Found Symp, 2000, 231: 270-283
26. Qu T, Brannen C L, Kim H M, et al. Human neural stem cells improve cognitive function of aged brain. Neuroreport, 2001, 12: 1127-1132
27. Wu P, Tarasenko Y I, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci, 2002, 5: 1271-1278
28. Wang Q, Matsumoto Y, Shindo T, et al. Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J Med Invest. 2006, 53(1-2): 61-69
29. Sugaya K, Kim H M, Qu T, et al. Physiological role of amyloid beta precursor protein in neural stem cell biology. Program No. 132.15. Abstract Viewer/Itinerary Planner. Washington: Society for Neuroscience, 2001
30. Kirazov E, Kirazov L, Bigl V, et al. Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int J Dev Neurosci, 2001, 19: 287-296
31. Murakami N, Yamaki T, Iwamoto Y, et al. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma, 1998, 15: 993-1003
32. Miyachi T, Asai K, Tsuiki H, et al. Interleukin-1beta induces the expression of lipocortin 1 mRNA in cultured rat cortical astrocytes. Neurosci Res, 2001, 40: 53-60
33. Sugaya K, Alvarez A, Marutle A, et al. Stem cell strategies for Alzheimer's disease therapy. Panminerva Med, 2006, 48(2): 87-96
34. Ende N, Chen R, Ende-Harris D. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. J Med, 2001, 32(3-4): 241-247
35. Chen C W, Boiteau R M, Lai W F, et al. sAPPalpha enhances the transdifferentiation of adult bone marrow progenitor cells to neuronal phenotypes. Curr Alzheimer Res, 2006, 3(1): 63-70
36. Pakzaban P, Deacon T, Burns L, et al. Increased proportion of AChE-rich zones and improved morphologic integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp Brain Res, 1993, 97: 13-22
37. Isacson O, Deacon T W, Pakzaban P, et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med, 1995, 1: 1189-1194
38. Freeman T B, Sanberg P R, Isacson O. Development of the human striatum: Implications for fetal striatal transplantation. Cell Transplant, 1995, 4: 539-545
39. Hantraye P, Riche D, Maziere M, et al. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci USA, 1992, 89: 4187-4191
40. Kendall A L, Rayment F D, Torres E M, et al. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med, 1998, 4: 727-729
41. Keene C D, Sonnen J A, Swanson P D, et al. Neural transplantation in Huntington disease: Long-term grafts in two patients. Neurology, 2007, 68(24): 2093-2098
42. Lescaudron L, Unni D, Dunbar G L. Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: Behavioral and morphological outcomes. Int J Neurosci, 2003, 113(7): 945-956
43. McBride J L, Behrstock S P, Chen E Y, et al. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol, 2004, 475(2): 211-219
44. Lee S T, Park J E, Lee K, et al. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease. J Neurosci Methods, 2006, 152(1-2): 250-254
45. Lee S T, Chu K, Park J E, et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res, 2005, 52(3): 243-249
46. Roberts T J, Price J, Williams S C, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience, 2006, 139(4): 1187-1199
47. Vazey E M, Chen K, Hughes S M, et al. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol, 2006,199: 384-396
48. Johann V, Schiefer J, Sass C, et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res, 2007, 177(4): 458-470
49. Bachoud-Levi A C, Gaura V, Brugieres P, et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long term follow up study. Lancet Neurol, 2006, 5: 303-309
50. Roberts T J, Price J, Williams S C, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience, 2006, 139(4): 1187-1199
51. Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol, 2003, 2: 417-424
52. Wichterle H, Lieberam I, Porter J, et al. Directed differentiation of embryonic stem cells into motor neurons. Cell, 2002, 110: 385-397
53. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res, 2005, 80(2): 182-190
54. Mazzini L, Mareschi K, Ferrero I, et al. Autologous mesenchymal stem cells: Clinical applications in amyotrophic lateral sclerosis. Neurol Res, 2006, 28(5): 523-526